The Open Science Advisory Services (OSAS) program provides funding to organizations and companies seeking third party advisory services related to advancing open science drug discovery. The funding is specifically intended to cover the cost of hiring third-party experts, such as consultants, legal advisors, or business strategists, to help address challenges related to innovation, intellectual property, commercialization, and business planning.
With a total of $4.9M available, OSAS supports projects that focus on areas where open sharing and collaboration are key to advancement and where market solutions are limited, such as rare or neglected diseases, pandemic preparedness, and antimicrobial resistance.
We are now accepting proposals until December 31, 2025. Firms or organizations interested in the program should complete the Initial application form at the link below. Applications will be reviewed on a rolling basis and selected applicants will be invited to submit a full proposal.
